These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 34619276

  • 1. Conformational flexibility of the conserved hydrophobic pocket of HIV-1 gp41. Implications for the discovery of small-molecule fusion inhibitors.
    Cano-Muñoz M, Jurado S, Morel B, Conejero-Lara F.
    Int J Biol Macromol; 2021 Dec 01; 192():90-99. PubMed ID: 34619276
    [Abstract] [Full Text] [Related]

  • 2. Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design.
    Cai L, Gochin M, Liu K.
    Curr Top Med Chem; 2011 Dec 01; 11(24):2959-84. PubMed ID: 22044229
    [Abstract] [Full Text] [Related]

  • 3. Thermodynamic dissection of the interface between HIV-1 gp41 heptad repeats reveals cooperative interactions and allosteric effects.
    Jurado S, Cano-Muñoz M, Polo-Megías D, Conejero-Lara F, Morel B.
    Arch Biochem Biophys; 2020 Jul 30; 688():108401. PubMed ID: 32376316
    [Abstract] [Full Text] [Related]

  • 4. The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors.
    Zhu Y, Ding X, Yu D, Chong H, He Y.
    J Virol; 2019 Dec 12; 94(1):. PubMed ID: 31619552
    [Abstract] [Full Text] [Related]

  • 5. Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.
    Su S, Zhu Y, Ye S, Qi Q, Xia S, Ma Z, Yu F, Wang Q, Zhang R, Jiang S, Lu L.
    J Virol; 2017 Jan 01; 91(1):. PubMed ID: 27795416
    [Abstract] [Full Text] [Related]

  • 6. Peptide and non-peptide HIV fusion inhibitors.
    Jiang S, Zhao Q, Debnath AK.
    Curr Pharm Des; 2002 Jan 01; 8(8):563-80. PubMed ID: 11945159
    [Abstract] [Full Text] [Related]

  • 7. HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain.
    Lu L, Tong P, Yu X, Pan C, Zou P, Chen YH, Jiang S.
    Biochim Biophys Acta; 2012 Dec 01; 1818(12):2950-7. PubMed ID: 22867851
    [Abstract] [Full Text] [Related]

  • 8. An amphiphilic conjugate approach toward the design and synthesis of betulinic acid-polyphenol conjugates as inhibitors of the HIV-1 gp41 fusion core formation.
    Liu Y, Ke Z, Wu KY, Liu S, Chen WH, Jiang S, Jiang ZH.
    ChemMedChem; 2011 Sep 05; 6(9):1654-64. PubMed ID: 21688394
    [Abstract] [Full Text] [Related]

  • 9. Identification of a human protein-derived HIV-1 fusion inhibitor targeting the gp41 fusion core structure.
    Chao L, Lu L, Yang H, Zhu Y, Li Y, Wang Q, Yu X, Jiang S, Chen YH.
    PLoS One; 2013 Sep 05; 8(5):e66156. PubMed ID: 23741527
    [Abstract] [Full Text] [Related]

  • 10. Probing Vulnerability of the gp41 C-Terminal Heptad Repeat as Target for Miniprotein HIV Inhibitors.
    Jurado S, Moog C, Cano-Muñoz M, Schmidt S, Laumond G, Ruocco V, Standoli S, Polo-Megías D, Conejero-Lara F, Morel B.
    J Mol Biol; 2020 Sep 18; 432(20):5577-5592. PubMed ID: 32822695
    [Abstract] [Full Text] [Related]

  • 11. Conformational Stabilization of Gp41-Mimetic Miniproteins Opens Up New Ways of Inhibiting HIV-1 Fusion.
    Cano-Muñoz M, Lucas J, Lin LY, Cesaro S, Moog C, Conejero-Lara F.
    Int J Mol Sci; 2022 Mar 03; 23(5):. PubMed ID: 35269936
    [Abstract] [Full Text] [Related]

  • 12. Conserved residue Lys574 in the cavity of HIV-1 Gp41 coiled-coil domain is critical for six-helix bundle stability and virus entry.
    He Y, Liu S, Jing W, Lu H, Cai D, Chin DJ, Debnath AK, Kirchhoff F, Jiang S.
    J Biol Chem; 2007 Aug 31; 282(35):25631-9. PubMed ID: 17616522
    [Abstract] [Full Text] [Related]

  • 13. Molecular dynamics studies of the inhibitor C34 binding to the wild-type and mutant HIV-1 gp41: inhibitory and drug resistant mechanism.
    Ma X, Tan J, Su M, Li C, Zhang X, Wang C.
    PLoS One; 2014 Aug 31; 9(11):e111923. PubMed ID: 25393106
    [Abstract] [Full Text] [Related]

  • 14. Extremely Thermostabilizing Core Mutations in Coiled-Coil Mimetic Proteins of HIV-1 gp41 Produce Diverse Effects on Target Binding but Do Not Affect Their Inhibitory Activity.
    Cano-Muñoz M, Cesaro S, Morel B, Lucas J, Moog C, Conejero-Lara F.
    Biomolecules; 2021 Apr 12; 11(4):. PubMed ID: 33921495
    [Abstract] [Full Text] [Related]

  • 15. Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015).
    Li W, Lu L, Li W, Jiang S.
    Expert Opin Ther Pat; 2017 Jun 12; 27(6):707-719. PubMed ID: 28076686
    [Abstract] [Full Text] [Related]

  • 16. Structural and Thermodynamic Analysis of HIV-1 Fusion Inhibition Using Small gp41 Mimetic Proteins.
    Jurado S, Cano-Muñoz M, Morel B, Standoli S, Santarossa E, Moog C, Schmidt S, Laumond G, Cámara-Artigas A, Conejero-Lara F.
    J Mol Biol; 2019 Aug 09; 431(17):3091-3106. PubMed ID: 31255705
    [Abstract] [Full Text] [Related]

  • 17. A multi-functional peptide as an HIV-1 entry inhibitor based on self-concentration, recognition, and covalent attachment.
    Zhao L, Tong P, Chen YX, Hu ZW, Wang K, Zhang YN, Zhao DS, Cai LF, Liu KL, Zhao YF, Li YM.
    Org Biomol Chem; 2012 Aug 28; 10(32):6512-20. PubMed ID: 22760295
    [Abstract] [Full Text] [Related]

  • 18. A novel bispecific peptide HIV-1 fusion inhibitor targeting the N-terminal heptad repeat and fusion peptide domains in gp41.
    Jiang X, Jia Q, Lu L, Yu F, Zheng J, Shi W, Cai L, Jiang S, Liu K.
    Amino Acids; 2016 Dec 28; 48(12):2867-2873. PubMed ID: 27631437
    [Abstract] [Full Text] [Related]

  • 19. ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer.
    Yu F, Lu L, Liu Q, Yu X, Wang L, He E, Zou P, Du L, Sanders RW, Liu S, Jiang S.
    Biochim Biophys Acta; 2014 May 28; 1838(5):1296-305. PubMed ID: 24388952
    [Abstract] [Full Text] [Related]

  • 20. Interactions of HIV-1 inhibitory peptide T20 with the gp41 N-HR coiled coil.
    Champagne K, Shishido A, Root MJ.
    J Biol Chem; 2009 Feb 06; 284(6):3619-27. PubMed ID: 19073602
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.